After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Healthcare Plans industry segment, falling under the Healthcare sector. The current market capitalization of Elevance Health Inc is $94.02B. A total of 1.89 million shares were traded on the day, compared to an average of 1.91M shares.
In the most recent transaction, Kendrick Charles Morgan JR sold 7,417 shares of ELV for 432.14 per share on Oct 18 ’24. After the transaction, the EVP & President, Commercial now owns 8,423 company shares. In a previous transaction on Oct 18 ’24, Kendrick Charles Morgan JR bought 7,417 shares at 432.28 per share.
Among the insiders who sold shares, PERU RAMIRO G disposed of 753 shares on Aug 05 ’24 at a per-share price of $531.52. This resulted in the Director holding 8,744 shares of ELV after the transaction. In another insider transaction, RAMIRO G PERU bought 753 shares at $531.52 per share on Aug 05 ’24.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Elevance Health Inc pays an annual dividend of $6.52, resulting in a dividend yield of 1.61%, and it has a price to earnings (P/E) ratio of 15.83. ELV’s most recent ex-dividend date was 1.75% when it declared a $1.71 quarterly dividend that was paid in cash on 3/10/2025. Previously, the company paid the dividend on 12/5/2024 with an ex-dividend date of 1.5%. The ELV stock dividend was $1.63 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ELV has a high of $567.26 and a low of $362.21.
As of this writing, ELV has an earnings estimate of $10.62 per share for the current quarter. EPS was calculated based on a consensus of 18.0 estimates, with a high estimate of $11.4 per share and a lower estimate of $9.55.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ELV’s latest balance sheet shows that the firm has $31.15B in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $188.74, while its Total Shareholder’s Equity was $36.13B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELV is Buy with a score of 4.45.
